---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-086313"
form_type: "8-K"
ticker: "UHS"
cik: "0000352915"
company_name: "UNIVERSAL HEALTH SERVICES INC"
filed_at: "2024-07-25T23:59:59+00:00"
generated_at: "2026-05-31T16:25:59.868030+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# UHS Q2 EPS $4.26 vs $2.42 YoY; raises 2024 guidance; adds $1B to buyback

## Summary
- Q2 net income $289.2M ($4.26 diluted EPS) vs $171.3M ($2.42) YoY; adjusted EPS $4.31.
- Net revenues $3.908B (+10.1% YoY); same-facility acute revenue +6.6%, behavioral +11.0%.
- Revised 2024 guidance: Adj. EPS $15.40-$16.20 (prev $13.00-$14.00); Adj. EBITDA $2.154B-$2.226B (prev $1.931B-$2.019B).
- Board authorizes $1B increase to stock repurchase program; total authorization now $1.228B.
- Operating cash flow $1.076B through June 2024 vs $654M in 2023, up 64%.

## SEC filing metadata
- accession: 0000950170-24-086313
- form_type: 8-K
- ticker: UHS
- cik: 0000352915
- company_name: UNIVERSAL HEALTH SERVICES INC
- filed_at: 2024-07-25T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/352915/000095017024086313/0000950170-24-086313-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/352915/000095017024086313/uhs-20240724.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-086313
- JSON: https://secwatch.observer/filing/0000950170-24-086313.json
- Plain text: https://secwatch.observer/filing/0000950170-24-086313.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.